BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/26/2020 1:58:32 AM | Browse: 483 | Download: 1347
 |
Received |
|
2020-04-13 17:54 |
|
Peer-Review Started |
|
2020-04-13 17:54 |
|
First Decision by Editorial Office Director |
|
2020-04-22 15:48 |
|
Return for Revision |
|
2020-04-22 15:48 |
|
Revised |
|
2020-07-05 17:45 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-07-16 12:07 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-07-19 20:49 |
|
Articles in Press |
|
2020-07-19 20:49 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-08-10 02:32 |
|
Publish the Manuscript Online |
|
2020-08-25 09:16 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
“Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, Jean-Pierre Bronowicki, Rodolphe Anty and Marc Bourlière |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xavier Adhoute, MD, Doctor, Doctor, Department of Gastroenterology and Hepatology, Hôpital Saint-Joseph, 26 Bd de Louvain, Marseille 13008, France. adhoute.xavier@neuf.fr |
| Key Words |
Hepatocellular carcinoma; Transarterial chemoembolization; “Six-and-twelve” score; Prognosis; Albumin-Bilirubin grade; Tumor nodularity, infiltrative nature of the tumor, alpha-fetoprotein, Child-Pugh class, and performance status score |
| Core Tip |
Not all-intermediate stage hepatocellular carcinoma (HCC) benefit from transarterial chemoembolization (TACE). The recent “six-and-twelve” (6&12) score is an easy to use prognostic model that ensure a quick and appropriate patient’ selection before the first TACE in Chinese cohorts. In this multicenter French cohort of HCC, the “6&12” score can also classify survival among recommended TACE candidates with a good prognostic performance. It may help clinicians in routine clinical practice. |
| Publish Date |
2020-08-25 09:16 |
| Citation |
Adhoute X, Pénaranda G, Raoul JL, Bronowicki JP, Anty R, Bourlière M. “Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort. World J Hepatol 2020; 12(8): 525-532
|
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i8/525.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i8.525 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
